Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshikazu Yonemitsu

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 13, 2006
[How to design the translational research--special reference to gene therapy products]Yoshikazu Yonemitsu
Current Cancer Drug Targets|June 10, 2008
Cancer neovascularization and proinflammatory microenvironmentsMitsuko Furuya, Yoshikazu Yonemitsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Antibody-induced arthritis]Akihisa Yamashita, Yoshikazu Yonemitsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Angiogenic growth factors in rheumatoid arthritis]Akihisa Yamashita, Yoshikazu Yonemitsu
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|February 1, 2005
[Development of new gene therapy strategies: a grand design for frontier medicine]Yoshikazu Yonemitsu, Katsuo Sueishi
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2008
Vascular endothelial growth factor targeted RNA interference as a modulator of angiogenesisPeter Celec, Yoshikazu Yonemitsu
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Dramatic improvement of DC-based immunotherapy against various malignanciesYui Harada, Yoshikazu Yonemitsu
Pathophysiology : the Official Journal of the International Society for Pathophysiology|September 15, 2004
Vascular endothelial growth factor - basic science and its clinical implicationsPeter Celec, Yoshikazu Yonemitsu
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 24, 2004
[Gene therapy: its history, current status, and future perspectives]Yoshikazu Yonemitsu, Katsuo Sueishi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 5, 2010
[New technologies for immunotherapy against cancer: development of cell expansion technology and viruses as immune boosters]Yui Harada, Yoshikazu Yonemitsu
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 13, 2006
[How to design the translational research--special reference to gene therapy products]Yoshikazu Yonemitsu
Current Cancer Drug Targets|June 10, 2008
Cancer neovascularization and proinflammatory microenvironmentsMitsuko Furuya, Yoshikazu Yonemitsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Antibody-induced arthritis]Akihisa Yamashita, Yoshikazu Yonemitsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Angiogenic growth factors in rheumatoid arthritis]Akihisa Yamashita, Yoshikazu Yonemitsu
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|February 1, 2005
[Development of new gene therapy strategies: a grand design for frontier medicine]Yoshikazu Yonemitsu, Katsuo Sueishi
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2008
Vascular endothelial growth factor targeted RNA interference as a modulator of angiogenesisPeter Celec, Yoshikazu Yonemitsu
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Dramatic improvement of DC-based immunotherapy against various malignanciesYui Harada, Yoshikazu Yonemitsu
Pathophysiology : the Official Journal of the International Society for Pathophysiology|September 15, 2004
Vascular endothelial growth factor - basic science and its clinical implicationsPeter Celec, Yoshikazu Yonemitsu
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 24, 2004
[Gene therapy: its history, current status, and future perspectives]Yoshikazu Yonemitsu, Katsuo Sueishi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 5, 2010
[New technologies for immunotherapy against cancer: development of cell expansion technology and viruses as immune boosters]Yui Harada, Yoshikazu Yonemitsu
Pageof 13